Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. annual/quarterly long term debt history from 2016 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Aptevo Therapeutics Inc. long term debt for the quarter ending December 31, 2022 were 4.0M, a 74.99% decrease year-over-year.
- Aptevo Therapeutics Inc. long term debt for 2022 were 4.0M, a 74.99% decrease from 2021.
- Aptevo Therapeutics Inc. long term debt for 2021 were 16.0M, a 43.23% decrease from 2020.
- Aptevo Therapeutics Inc. long term debt for 2020 were 28.2M, a 46.38% increase from 2018.
- Aptevo Therapeutics Inc. long term debt for 2018 were 19.3M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aptevo Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $4 |
| 2021 | $16 |
| 2020 | $28 |
| 2018 | $19 |
| 2017 | $16 |
| 2016 | $18 |
| Aptevo Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2022-12-31 | $4 |
| 2021-12-31 | $16 |
| 2020-12-31 | $28 |
| 2018-12-31 | $19 |
| 2017-12-31 | $16 |
| 2016-12-31 | $18 |
Aptevo Therapeutics Inc. Long Term Debt — FAQ
Aptevo Therapeutics Inc. (APVO) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APVO's long term debt history?
The chart and table above show Aptevo Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.